山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (6): 77-82.doi: 10.6040/j.issn.1673-3770.0.2020.537

• • 上一篇    下一篇

鼻腔鼻窦神经内分泌癌8例并文献复习

陈学军,高文,尹高菲,郭伟,黄俊伟,张洋   

  1. 首都医科大学附属北京同仁医院 耳鼻咽喉头颈外科/耳鼻咽喉头颈科学教育部重点实验室, 北京 100730
  • 发布日期:2021-12-10
  • 通讯作者: 张洋. E-mail:zhangyangent@163.com
  • 基金资助:
    国家自然科学基金(82072997)

Neuroendocrine carcinoma of the nasal cavity and paranasal sinus: eight cases and literature review

CHEN Xuejun, GAO Wen, YIN Gaofei, GUO Wei, HUANG Junwei, ZHANG Yang   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University / Key Laboratory of Otolaryngology-Head and Neck Surgery, Ministry of Education, Beijing 100730, China
  • Published:2021-12-10

PDF (PC)

296

摘要： 目的 探讨鼻腔鼻窦神经内分泌癌的临床特征、病理表现、治疗手段、预后及影响预后的因素。 方法 回顾经病理证实的8例原发性鼻腔鼻窦神经内分泌癌患者的临床病例资料。 结果 随访5~70个月,中位随访时间23个月, 8例中典型类癌1例、不典型类癌4例、小细胞神经内分泌癌2例、复合型神经内分泌癌1例(低分化神经内分泌癌伴内翻性乳头状瘤);平均46岁(34~57岁);T2期2例,T4期6例;接受手术7例,接受放疗6例,接受化疗6例,以手术+术后放化疗为最常见的治疗方式。 结论 神经内分泌癌最终确诊依靠术后病理和免疫组化指标,主要影响生存率的不良预后因素包括病理亚型和相关的治疗方式的选择。典型类癌、不典型类癌首选手术治疗,对于低分化亚型的神经内分泌癌,综合治疗对肿瘤局部控制和延长生存期有帮助。

关键词: 鼻腔鼻窦肿瘤, 神经内分泌癌, 典型/不典型类癌, 小细胞神经内分泌癌, 复合型神经内分泌癌

Abstract: ObjectiveTo investigate the clinical and pathological features, treatment, prognosis, and prognostic factors of neuroendocrine carcinoma of the nasal cavity and paranasal sinus. MethodsThe clinical data of 8 pathologically confirmed primary neuroendocrine carcinomas of the nasal cavity and paranasal sinus were reviewed. ResultsThe followup durations were 570 months, with a median of 23 months. Eight cases of nasal sinus neuroendocrine carcinoma were reviewed: 1 case of typical carcinoid tumor, 4 cases of atypical carcinoid tumor, 2 cases of small cell neuroendocrine carcinoma, and 1 case of complex neuroendocrine carcinoma (poorly differentiated neuroendocrine carcinoma with varus papilloma). The mean age of the patients was 46 years (3457 years). The stage of the malignant tumor in the nasal cavity and paranasal sinus was T2 in 2 patients and T4 in 6 patients. The cases were treated as follows: surgery, 7 cases; radiotherapy, 6 cases; and chemotherapy, 6 cases. Surgery plus postoperative chemoradiotherapy was the most common treatment. Conclusion The final diagnosis of neuroendocrine carcinoma depends on postoperative pathological and immunohistochemical indicators. The major adverse prognostic factors affecting the survival rate included the pathological subtypes and the associated treatment options. Surgical treatment is the first choice for typical and atypical carcinomas. For poorly differentiated subtypes of neuroendocrine carcinoma, comprehensive treatment is the most effective method for local tumor control and prolonged survival.

中图分类号: 

  • R739.62
[1] Van der Laan TP, Iepsma R, Witjes MJ, et al. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy[J].Oral Oncol, 2016,63:1-9. doi: 10.1016/j.oraloncology.2016.10.002.
[2] 陈红, 曹慧玲, 窦鑫, 等. 右侧鼻腔小细胞神经内分泌癌一例并文献复习[J]. 山东大学耳鼻喉眼学报, 2018,32(1): 89-92. doi: 10.6040 / j.issn.1673-3770.0.2017.300. CHEN Hong, CAO Huiling, DOU Xin, et al. Small cell neuroendocrine carcinoma in the right nasal cavity: a report of one case and a literature review[J]. J Otolaryngol Ophthalmol Shandong Univ, 2018,32(1): 89-92. doi: 10.6040/j.issn.1673-3770.0.2017.300.
[3] Jayme EM, Morimoto TP, Lozano TM, et al. Sphenoid sinus neuroendocrine carcinoma[J]. Bjr|case Rep, 2017, 3(1): 20150334. doi:10.1259/bjrcr.20150334.
[4] Mitchell EH, Diaz A, Yilmaz T, et al. Multimodality treatment for sinonasal neuroendocrine carcinoma[J]. Head Neck, 2012,34(10):1372-1376. doi: 10.1002/hed.21940.
[5] Mhawej R, Farah C, Haddad A, et al. Primary neuroendocrine tumors of the ear, nose and throat: A report of three cases and a review of the literature[J]. Oncol Lett, 2015,10(4):2533-2536. doi: 10.3892/ol.2015.3606.
[6] Gudlavalleti A, Dean R, Liu YX, et al. Diagnosis and treatment of a rare sinonasal neuroendocrine tumour: adding to the evidence[J]. BMJ Case Rep, 2016, 2016: bcr2016217319. doi:10.1136/bcr-2016-217319.
[7] Perez-Ordonez B, Caruana SM, Huvos AG, et al. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses[J]. Hum Pathol, 1998, 29(8): 826-832. doi:10.1016/s0046-8177(98)90452-x.
[8] van der Laan TP, Plaat BE, van der Laan BF, et al. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: a meta-analysis of 436 reported cases[J]. Head Neck, 2015, 37(5): 707-715. doi:10.1002/hed.23666.
[9] 张洋, 段翰源, 李祖飞, 等. 25例喉神经内分泌癌的诊治与临床分析[J]. 肿瘤预防与治疗, 2019, 32(7): 607-611. doi:10.3969/j.issn.1674-0904.2019.07.009. ZHANG Yang, DUAN Hanyuan, LI Zufei, et al. Diagnosis, treatment and clinical analysis of 25 cases of laryngeal neu-roendocrine carcinoma[J]. J Cancer Control Treat, 2019, 32(7): 607-611. doi:10.3969/j.issn.1674-0904.2019.07.009.
[10] Shah K, Perez-Ordóñez B. Neuroendocrine neoplasms of the sinonasal tract: neuroendocrine carcinomas and olfactory neuroblastoma[J]. Head Neck Pathol, 2016, 10(1): 85-94. doi:10.1007/s12105-016-0696-7.
[11] 张青,朱庆强,吴晶涛,等.鼻窦神经内分泌癌的CT和MRI诊断[J].中华放射学杂志,2012(7):615-618. doi:10.3760/cma.j.issn.1005-1201.2012.07.008. ZHANG Qing, ZHU Qingqiang, WU Jingtao, et al. CT and MRI diagnosis of neuroendocrine carcinoma in paranasal sinuses[J]. Chinese Journal of Radiology, 2012(7):615-618. doi:10.3760/cma.j.issn.1005-1201.2012.07.008.
[12] Lahma J, Hejjouji R, Gicquel P, et al. Large cell neuroendocrine carcinoma of the nasal cavity: an extremely rare and new distinct entity[J]. Pan Afr Med J,2018,29(30):188. doi: 10.11604/pamj.2018.30.188.14992.
[13] 徐建明, 梁后杰, 秦叔逵, 等. 中国胃肠胰神经内分泌肿瘤专家共识(2016年版)[J]. 临床肿瘤学杂志, 2016,21(10): 927-946.
[14] 李采, 周梁, 沈雁, 等. 喉神经内分泌癌[J]. 临床耳鼻咽喉头颈外科杂志, 2009, 23(21): 970-972. doi:10.3969/j.issn.1001-1781.2009.21.004. LI Cai, ZHOU Liang, SHEN Yan, et al. Clinical analysis of laryngeal neuroendocrine carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2009, 23(21): 970-972. doi:10.3969/j.issn.1001-1781.2009.21.004.
[15] Meacham R, Matrka L, Ozer E, et al. Neuroendocrine carcinoma of the head and neck: a 20-year case series[J]. Ear Nose Throat J, 2012, 91(3): E20-E24. doi:10.1177/014556131209100317.
[16] 徐丽, 关兵, 彭新, 等. 鼻窦低分化神经内分泌癌6例临床分析[J]. 临床耳鼻咽喉头颈外科杂志, 2013,27(5): 236-238. doi:10.13201/j.issn.1001-1781.2013.05.008. XU Li, GUAN Bing, PENG Xin, et al. Analysis on 6 cases with nasal neuroendocrine carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2013,27(5): 236-238. doi:10.13201/j.issn.1001-1781.2013.05.008.
[17] Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas[J]. Mod Pathol, 2002, 15(3): 264-278. doi:10.1038/modpathol.3880522.
[18] Bell D. Sinonasal neuroendocrine neoplasms: current challenges and advances in diagnosis and treatment, with a focus on olfactory neuroblastoma[J]. Head Neck Pathol, 2018, 12(1): 22-30. doi:10.1007/s12105-018-0887-5.
[19] Furuta A, Kudo M, Kanai K, et al. Typical carcinoid tumor arising in the nose and paranasal sinuses-case report[J]. Auris Nasus Larynx, 2010, 37(3): 381-385. doi: 10.1016/j.anl.2009.09.007.
[20] Rivero A, Liang J. Sinonasal small cell neuroendocrine carcinoma: a systematic review of 80 patients[J]. Int Forum Allergy Rhinol, 2016, 6(7): 744-751. doi:10.1002/alr.21734.
[1] 刘玉柱,苑铁君,李波. 会厌原发神经内分泌癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 97-100.
[2] 毛泽凡陈曦,程雷. 喉神经内分泌癌的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 114-119.
[3] 高天喜,李娜,李桔林,张阿玲,祝康,陈敬国,孙斌. 气囊导尿管在鼻腔鼻窦肿瘤切除术后术腔填塞中的应用[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 11-15.
[4] 陈红,曹慧玲,窦鑫,高下. 右侧鼻腔小细胞神经内分泌癌一例并文献复习[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 89-92.
[5] 唐智，王继群，李玉兰，陈勇明，涂智峰. 鳞状细胞癌抗原在鼻腔鼻窦鳞癌患者血清中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 24-25.
[6] 王小婷，时光刚，刘亦青，纪宏志，何明强，李建峰，王海波. 少年和老人鼻腔、鼻窦肿瘤[J]. 山东大学耳鼻喉眼学报, 2011, 25(6): 19-22.
[7] 温晗光，陈缪安，林忠豪，蔡志良. 喉神经内分泌癌1例[J]. 山东大学耳鼻喉眼学报, 2011, 25(4): 73-74.
[8] 侯东明 曹荣萍 孟国珍 杨军. 儿童鼻腔鼻窦肿瘤在内镜辅助下的诊断及手术治疗[J]. 山东大学耳鼻喉眼学报, 2008, 22(6): 515-516.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发